Mizuho Securities USA’s Aimei Health Technology Co AFJK Stock Holding History

Mizuho Securities USA’s Portfolio AFJK Stock Details AFJK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-550,658	Closed	-$6.11M	–	703
2025 Q3	$6.11M	Buy	550,658 +58	+0%	+$652	0.12%	160
2025 Q2	$6.06M	Buy	550,600 +600	+0.1%	+$6.65K	0.13%	159
2025 Q1	$6.02M	Sell	550,000 -347,220	-39%	-$3.76M	0.13%	160
2024 Q4	$9.42M	Buy	897,220 +454,442	+103%	+$4.81M	0.17%	110
2024 Q3	$4.63M	Buy	442,778 +167,223	+61%	+$1.74M	0.1%	187
2024 Q2	$2.82M	Buy	275,555 +7,212	+3%	+$74.3K	0.06%	293
2024 Q1	$2.72M	Buy	+268,343	New	+$2.73M	0.07%	69

Other funds holding AFJK

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DWM

Dakota Wealth Management Palm Beach Gardens, Florida $5.24B AUM 38.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mizuho Securities USA's AFJK Position: Q4 2025 in Review

Mizuho Securities USA sold out of Aimei Health Technology Co (AFJK) in Q4 2025, closing a stake of 550,658 shares — an estimated $6.11M sold.

Mizuho Securities USA first reported a position in AFJK in Q1 2024 and held it in 7 quarters. The position peaked at $9.42M in Q4 2024. 11 funds tracked by Wall St. Rank hold AFJK as of Q4 2025.

Mizuho Securities USA reported no remaining Aimei Health Technology Co position as of Q4 2025 after selling out during the quarter.
Mizuho Securities USA sold 550,658 Aimei Health Technology Co shares in Q4 2025, an estimated $6.11M.
Mizuho Securities USA first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 7 quarters.
Mizuho Securities USA's Aimei Health Technology Co position peaked at $9.42M in Q4 2024.
11 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q4 2025.

Based on Mizuho Securities USA's 13F filing for Q4 2025, filed 9 Feb 2026.